Frankfurt - Delayed Quote EUR

Akebia Therapeutics, Inc. (AX9.F)

Compare
2.2020
-0.0420
(-1.87%)
At close: January 24 at 8:02:39 AM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
241,703.0000
356,054.0000
529,347.0000
644,139.0000
Total Liabilities Net Minority Interest
272,287.0000
350,824.0000
455,339.0000
396,521.0000
Total Equity Gross Minority Interest
-30,584.0000
5,230.0000
74,008.0000
247,618.0000
Total Capitalization
-13,401.0000
39,308.0000
74,008.0000
343,996.0000
Common Stock Equity
-30,584.0000
5,230.0000
74,008.0000
247,618.0000
Capital Lease Obligations
13,438.0000
33,705.0000
38,505.0000
29,907.0000
Net Tangible Assets
-125,670.0000
-125,898.0000
-93,163.0000
48,395.0000
Working Capital
18,279.0000
55,646.0000
10,098.0000
184,291.0000
Invested Capital
4,099.0000
71,308.0000
171,551.0000
343,996.0000
Tangible Book Value
-125,670.0000
-125,898.0000
-93,163.0000
48,395.0000
Total Debt
48,121.0000
99,783.0000
136,048.0000
126,285.0000
Share Issued
194,582.5390
184,135.7140
177,000.9630
148,074.0850
Ordinary Shares Number
194,582.5390
184,135.7140
177,000.9630
148,074.0850
12/31/2020 - 4/1/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers